Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Share price - Overview

Stock Report

Agios Pharmaceuticals Inc AGIO

Last Price
$46.99

Day Change
0.00|0.00%

As of 21/04/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close46.99
Day Range46.92 - 48.59
Mkt Cap1.99Bil
52-Wk Range36.00 - 67.65
Yield %-
ISINUS00847X1046
Volume311,684
P/E-9.27
P/S26.32
P/CF47.68

Share Price

Financials
201420152016
More ...
Income Statement
Revenue65.3659.1269.89
Operating Income-54.13-118.70-200.99
Net Income-53.50-117.73-198.47
Basic EPS-1.59-3.15-5.07
Avg. Diluted Shares Outstanding343739
Balance Sheet
Current Assets359.55337.33559.89
Non Current Assets132.3682.7459.20
Total Assets491.90420.07619.09
Current Liabilities61.0952.8988.43
Total Liabilities67.5474.95260.50
Total Equity424.37345.12358.59
Cash Flow
Operating Cash Flow-59.35-76.9538.56
Capital Expenditure-2.22-20.16-9.92
Free Cash Flow-61.57-97.1128.65

In millions, except "Basic EPS". Currency is USD.

Company Profile

Agios Pharmaceuticals Inc is engaged in the development of medicines to treat cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

287
Key Stats
More ...
Price/Earning TTM-9.27
Price/Book5.53
Price/Sales TTM26.31
Rev Growth (3 year avg)39.86
EPS Growth (3 year avg)-
Operating Margin % TTM-287.57
Net Margin % TTM-283.97
ROE TTM-56.41
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.